• S1E1 - SGLT-2 Inhibitors Morning Commute: A Mechanistic Explanation of Renal Benefit

  • 2021/02/27
  • 再生時間: 27 分
  • ポッドキャスト

S1E1 - SGLT-2 Inhibitors Morning Commute: A Mechanistic Explanation of Renal Benefit

  • サマリー

  • Visit http://morningcommutepodcast.com/SGLT2inhibitors1 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, our experts will be discussing sodium-glucose cotransporter 2 (SGLT-2) inhibitors and their role beyond glycemic control. What are the mechanisms and renal benefit of SGLT-2 inhibitors?

    続きを読む 一部表示

あらすじ・解説

Visit http://morningcommutepodcast.com/SGLT2inhibitors1 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, our experts will be discussing sodium-glucose cotransporter 2 (SGLT-2) inhibitors and their role beyond glycemic control. What are the mechanisms and renal benefit of SGLT-2 inhibitors?

S1E1 - SGLT-2 Inhibitors Morning Commute: A Mechanistic Explanation of Renal Benefitに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。